The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder
The company is working closely with its six manufacturing partners in India
Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021
The company has posted net profit of Rs.35.03 crores for the period ended March 31, 2020
The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021
TCLS USA expects to start production by the late summer of 2023.
FY21 revenues from operations stood at Rs. 709.3 crore as against Rs. 600.1 crore for FY20, higher by 18.2%
Orica intends to run a sale process for the Minova business,
The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months
The transaction will take place in two tranches, with IMCD now acquiring 80% of Siliconas y Químicos’ share capital and the remaining 20% in 2022
The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield
Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India
The company reported total income of Rs.38952 crores during the 12 months period ended March 31, 2021
The company's focus is on development of molecules in which it has core competencies, rather than on import substituting products.
Yasho Industries Ltd has reported total income of Rs.369.52 crores during the 12 months period ended March 31, 2021
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
Many leading Indian chemical companies tapped the IPO route to raise funds worth approximately Rs. 4,000 crores during FY 2020-21
Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.269.32 crores for FY ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
